Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-guided Transurethral Ultrasound Ablation for Localized Prostate Cancer

NCT03814252 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.

NCT NCT03814252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03814252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-guided Transurethral Ultrasound Ablation for Localized Prostate Cancer
Lead sponsor
Turku University Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 30, 2018
Completion date
December 31, 2028
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized prostate cancer